714971-27-4 Usage
Uses
Used in Medicinal Chemistry:
(R)-(4-Benzylmorpholin-3-yl)methanol hydrochloride is used as a building block for the synthesis of pharmaceutical drugs. Its unique structure and properties allow it to be a valuable component in creating new and effective medications.
Used in Drug Research:
In drug research, (R)-(4-Benzylmorpholin-3-yl)methanol hydrochloride serves as a reference standard in analytical chemistry. Its specific properties and potential uses can be further explored and optimized through research and testing, making it a valuable tool in the development of novel therapeutic agents.
Used in Pharmaceutical Drug Synthesis:
(R)-(4-Benzylmorpholin-3-yl)methanol hydrochloride is used as a key component in the synthesis of various pharmaceutical drugs. Its interactions with biological targets make it a promising candidate for the development of new medications with specific therapeutic applications.
Used in Analytical Chemistry as a Reference Standard:
(R)-(4-Benzylmorpholin-3-yl)methanol hydrochloride is utilized as a reference standard in analytical chemistry. Its well-defined properties and purity make it an ideal candidate for comparison and calibration purposes in various analytical techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 714971-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,4,9,7 and 1 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 714971-27:
(8*7)+(7*1)+(6*4)+(5*9)+(4*7)+(3*1)+(2*2)+(1*7)=174
174 % 10 = 4
So 714971-27-4 is a valid CAS Registry Number.
714971-27-4Relevant academic research and scientific papers
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H- indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epide
Gavai, Ashvinikumar V.,Fink, Brian E.,Fairfax, David J.,Martin, Gregory S.,Rossiter, Lana M.,Holst, Christian L.,Kim, Soong-Hoon,Leavitt, Kenneth J.,Mastalerz, Harold,Han, Wen-Ching,Norris, Derek,Goyal, Bindu,Swaminathan, Shankar,Patel, Bharat,Mathur, Arvind,Vyas, Dolatrai M.,Tokarski, John S.,Chiang, Yu,Oppenheimer, Simone,Hongjian, Zhang,Marathe, Punit,Fargnoli, Joseph,Lee, Francis Y.,Wong, Tai W.,Vite, Gregory D.
supporting information; experimental part, p. 6527 - 6530 (2010/03/26)
Structure-activity relationships in a series of 4-[1H-indazol-5-ylamino] pyrrolo[2,1-f][1,2,4]triazine-6-carbamates identified dual human epidermal growth factor receptor (HER)1/HER2 kinase inhibitors with excellent biochemical potency and kinase selectiv
SYNTHETIC PROCESS
-
, (2008/06/13)
The present invention provides a process for preparing compounds of formula (I) ["insert chemical structure here"](I)or a pharmaceutically acceptable salt thereof. The compounds prepared by the process of the invention inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2 and HER4 thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
